FLR vs HXL
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Fluor Corporation exhibits severe operational distress, highlighted by a critical Piotroski F-Score of 0/9, indicating a total lack of improvement in financial health across all measured dimensions. Despite a stable balance sheet with low debt and healthy liquidity ratios, the company is suffering from negative profit and gross margins and a catastrophic recent earnings miss (Actual $-9.87 vs Est $0.36). The combination of declining revenue, massive EPS contraction, and bearish insider selling outweighs the optimistic analyst target prices.
HXL presents a dichotomy between strong growth and extreme overvaluation. The deterministic health is mediocre with a Piotroski F-Score of 4/9, and the stock is trading at a severe premium, with the current price of $92.30 far exceeding both the Graham Number ($23.89) and the growth-based Intrinsic Value ($44.55). While earnings growth is robust at 40% YoY and liquidity is strong, the high P/E ratio and bearish insider sentiment suggest the current price has priced in far more than the fundamentals support. The divergence between recent price gains and a very low technical trend score (10/100) indicates a high risk of a correction.
Compare Another Pair
Related Comparisons
FLR vs HXL: Head-to-Head Comparison
This page compares Fluor Corporation (FLR) and Hexcel Corporation (HXL) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.